Navigation Links
Results for Wet Age-Related Macular Degeneration Show Significant Vision Improvements

Research conducted by retina surgeons at The Methodist Hospital shows unprecedented improvements in vision in more than one-third of patients treated with Lucentis? for wet// age-related macular degeneration (AMD), according to findings published today in the New England Journal of Medicine. AMD is a major cause of central visual loss and is one of the leading causes of blindness in people over 60.

Dr. David M. Brown, retinal surgeon with Vitreoretinal Consultants at The Methodist Hospital, is lead author on the ANCHOR study and a secondary author on the MARINA study. Brown enrolled more patients than any other site worldwide in the studies, which contributed to the U.S. Food and Drug Administration’s June approval of Lucentis for the treatment of patients with wet AMD.

“Lucentis therapy is the most significant advance in the treatment of macular degeneration in the history of the disease,” said Brown. “The ANCHOR study compared the previous treatment for macular degeneration (photodynamic therapy) with Lucentis in the most aggressive form of the disease. While 60 percent of the eyes treated with photodynamic therapy were legally blind at the end of the first year of study, patients who received Lucentis treatment were able to avoid legal blindness in seven out of eight cases. Seven percent of the Lucentis-treated patients improved to 20/20 vision at the one year endpoint. It truly made a remarkable difference in many of these patient’s lives enabling them to maintain driving and keep their independence.”

Data from the two randomized, controlled pivotal Phase III clinical trials of Lucentis (ranibizumab injection) shows that at one year, 95 percent of patients treated with Lucentis did not lose vision. Of these patients, 55 percent maintained their vision (defined as a loss of less than 15 letters in visual acuity) and up to 40 percent experienced an improvement of three lines (15 letters) or more on the study eye chart. In the MA
'"/>




Page: 1 2

Related medicine news :

1. Hormone Deficiency Results In Miscarriage
2. Breast Implants May Interfere With The Interpretation Of Mammogram Results
3. DNA Testing For More Accurate Results
4. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
5. Intense Fight Against Polio In India Gets Results
6. Deadly Diarrhoea Vaccine – Trail Results Promising
7. Novartis MS Drug Shows Promising Results
8. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
9. Dealing With Stress Results In Better Academic Performance
10. Excess Intake of Alcohol Results in Permanent DNA Damage.
11. Study Reveals Better Results in Patients Suffering From Depression.
Post Your Comments:
(Date:10/7/2008)...t in post-HAART era , , TUESDAY, Oct. 7 ...earch finds little evidence that circumcision prot...ut the issue is still far from settled. , For o...werful AIDS drugs showed that circumcision did hav...nched the most definitive type of research into th...
(Date:10/7/2008)...ter at the University of California, San Diego (UC...less march of advanced lung cancer by treating pat...any vaccines attempt to pump up the immune system ...s genetically engineered to also trick the cancer ...ivities. , The first patients have begun enrolli...
(Date:10/7/2008)...quest comes at stem cell symposium, ANN ARBOR, Mi...ne year,ago, retail pioneer A. Alfred Taubman anno...igan, to endow a new research institute aimed at,u...e., Today, at the institute,s first symposium, he...an additional $22 million to the,University for th...
(Date:10/7/2008)...E NATION HAVE SAID ,I VOTE FOR THE ...ire/ -- To aid and help educate tonight,s debate,w...idential candidates,Senators John McCain and Barac...Susan G. Komen for the Cure(R) Advocacy Alliance t...ts web site --, http://www.IVotefortheCure.org ., ...
Breaking Medicine News(10 mins):Health News:Role of Circumcision in Reducing HIV Risk Still Unclear 2Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...vidence to implicate insulin-like growth factor re...ase.// In a previous research, Terry J. Smith, M.... the interaction between immunoglobulins and IGF-1...ocyte infiltration in both Graves’ disease and rhe...
...ind a cure for deafness. As a leader in stem cell-...iversity School of Medicine,// he's got a step-by-... take another decade or so, but if anyone can do i...ur bets on. 'Everyone asks, 'How long before we d...
...tion of East Caribbean States (OECS) have said sch...ntion studies to their respective curricula. Arse... pandemic has raised concern of great magnitude in...tistics, the year 2006 saw 170,000 new cases of in...
...ally Administered Tribal Area (FARA) was the secon...t the immunization //drive carried out by the gove... chief surgeon at the main government hospital in ...olled roadside bomb exploded in Salarzai, a villag...
Other Medicine News:Health News:A Single Biological Mechanism Behind Several Autoimmune Disorders 2Health News:Stem Cell Transplants Explored as a Possible Treatment for Hearing Loss 2
(Date:10/7/2008)...tCall/ -- CEL-SCI Corporation,(NYSE: CVM ) announ...sfer,Agreement (MTA) with the National Institutes ...ry of Dr. Francesco M. Marincola, M.D., to,investi...icroenvironment,caused by CEL-SCI,s cancer drug Mu...ous Disease and Immunogentics Section, Department ...
(Date:10/7/2008).../ -- Aerovance Inc. today reported,pharmacokinetic...Aerovant,inhalation powder that demonstrate good t...llowing asthma patients, inhalation of a single 10... three doses investigated in,Aerovance,s Phase IIb...arly,next year. Evidence gathered from nonclinical...
(Date:10/7/2008)... Tests for Use on the GeneXpert(R) ...7 /- Cepheid (Nasdaq:,CPHD)...B as a European CE,IVD Mark product under the Euro...ces. The test delivers rapid detection of vanA and... with vancomycin-resistant,enterococci (VRE) -- on...
(Date:10/6/2008)...e/ -- "A return to the use of,chimpanzees in AIDS ...ific,justification," according to a paper released...nimals (ATLA). "An Assessment of the Role of,Chimp...ccine responses in,chimpanzees are not predictive ...zees, critical role and importance in AIDS vaccine...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 1Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 1University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 3Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 1Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 2Fruit and vegetables health 3210 1
...fety of Gene Therapy in Lipoprotein Lipase,Deficie... 31, 2007 - Amsterdam Molecular,Therapeutics (AMT)...orted positive Phase I/II clinical trial results w...MT-011) in Complete,Lipoprotein Lipase (LPL) defic...erican Society of Gene Therapy (ASGT) in Seattle.,...
...rom XL880, Phase II data from XL999 studies,schedu...-, SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-F...ata from clinical trials of,the company,s investig...d at the 2007 American Society of Clinical Oncolog...1 to 5 in Chicago,Illinois. , , -- Data from t...
Other Medicine Technology:AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
...ontinuous low-flow nebulizer performance. Patented...allows for optimal medication and Heliox delivery ...vere asthma, COPD and pneumonia in both routine an... mouth and T-piece to deliver high-output, low-flo...
... diverse medical products for more than 58 years. ...anding reputation for innovation, quality and cust...ecognized brands include the Labtron® line of ... products, Bristoline® microscopes, HealthTeam...
...contains everything the health care professional n...ickly and efficiently: 7 nebulizers, T-piece and m...yringe and needle., ,Shipped 5 kits per case., ,...ed Use: AsthmaKit is a procedural kit providing th...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only
Medicine Products: